Results for this period
Interim period (second quarter)1 September 2025–28 February 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Research and development expenses were ¥510 million, down 36.2% year on year, while other selling, general and administrative expenses were ¥152 million, down 22.5% year on year.
Although disclosures have been made regarding material events or conditions that may cast significant doubt on the going-concern assumption, the funds necessary to continue operations for the next year have been secured, and no material uncertainty regarding the going-concern assumption has been identified. There are no notes applicable to the going-concern assumption.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 September 2025–28 February 2026 |
| Operating profit | ¥-662 million |
| Ordinary income | ¥-632 million |
| Profit attributable to owners of the parent | ¥-633 million |
| Net income per share | (¥8.95) |
| Equity ratio | End of the current fiscal period 91.8 / End of previous period 90.8 |
| Total assets | ¥2,512 million |
| Net assets | ¥2,315 million |
| Cash flows from operating activities | ¥-611,138 thousand |
| Cash flows from investing activities | ¥53 thousand |
| Cash flows from financing activities | ¥509,889 thousand |
| Cash and cash equivalents at end of period | ¥2,447,760 thousand |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit ¥-2,008 million / Ordinary income ¥-1,958 million / Net income ¥-1,960 million |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Disclosure regarding the going concern assumption | Although disclosures have been made regarding material events or conditions that may cast significant doubt on the going-concern assumption, the funds necessary to continue operations for the next year have been secured, and no material uncertainty regarding the going-concern assumption has been identified. There are no notes applicable to the going-concern assumption. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | Between 1 March and 31 March 2026, part of the ninth series of stock acquisition rights was exercised, resulting in the issuance of 1,485,500 common shares. Capital stock and capital surplus each increased by ¥88,700 thousand, and the total number of shares issued as of 31 March was 75,216,400. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (participants not specified) |
| Issued Shares at Period-End | 73,730,900 shares |
| Treasury Shares at Period-End | 0 shares |
| Factors Behind Changes in Business Performance | Research and development expenses were ¥510 million, down 36.2% year on year, while other selling, general and administrative expenses were ¥152 million, down 22.5% year on year. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Research and development expenses were ¥510 million, down 36.2% year on year, while other selling, general and administrative expenses were ¥152 million, down 22.5%.